CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 15, 2019, 12:21 p.m.

/zigman2/quotes/201917619/composite

$

4.78

Change

+0.37 +8.28%

Volume

Volume 349,039

Real time quotes

/zigman2/quotes/201917619/composite

Previous close

$ 4.41

$ 4.78

Change

+0.37 +8.28%

Day low

Day high

$4.42

$4.78

Open

52 week low

52 week high

$4.23

$14.00

Open

Annual Financials for CymaBay Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20142015201620172018 5-year trend
Sales/Revenue ---10M-
Cost of Goods Sold (COGS) incl. D&A 18,00022,00029,000-105,000
COGS excluding D&A -----
Depreciation & Amortization Expense 18,00022,00029,00035,000105,000
Depreciation 18,00022,00029,00035,000105,000
Amortization of Intangibles -----
Gross Income (18,000)(22,000)(29,000)-(105,000)
20142015201620172018 5-year trend
SG&A Expense 23.99M25.88M25.56M31.29M72.4M
Research & Development 15.81M17.03M15.94M18.94M58.12M
Other SG&A 8.19M8.85M9.62M12.35M14.28M
Other Operating Expense -----
Unusual Expense 14.44M(11.12M)(76,000)5.77M407,000
EBIT after Unusual Expense (38.44M)(14.78M)(25.51M)(27.1M)(72.91M)
Non Operating Income/Expense 7.21M---(3.29M)
Non-Operating Interest Income 74,000160,000176,000621,0003.99M
Equity in Affiliates (Pretax) -----
Interest Expense 755,000913,0001.34M1.08M336,000
Gross Interest Expense 755,000913,0001.34M1.08M336,000
Interest Capitalized -----
Pretax Income (31.92M)(15.53M)(26.67M)(27.56M)(72.55M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (31.92M)(15.53M)(26.67M)(27.56M)(72.55M)
Minority Interest Expense -----
Net Income (31.92M)(15.53M)(26.67M)(27.56M)(72.55M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (31.92M)(15.53M)(26.67M)(27.56M)(72.55M)
Preferred Dividends -----
Net Income Available to Common (31.92M)(15.53M)(26.67M)(27.56M)(72.55M)
EPS (Basic) (2.65)(0.82)(1.14)(0.79)(1.26)
Basic Shares Outstanding 12.05M18.9M23.45M34.9M57.81M
EPS (Diluted) (2.65)(0.83)(1.14)(0.79)(1.26)
Diluted Shares Outstanding 12.05M18.9M23.45M34.9M57.81M
EBITDA (23.99M)(25.88M)(25.56M)(21.29M)(72.4M)
Link to MarketWatch's Slice.